NO20012825L - Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering - Google Patents
Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhaleringInfo
- Publication number
- NO20012825L NO20012825L NO20012825A NO20012825A NO20012825L NO 20012825 L NO20012825 L NO 20012825L NO 20012825 A NO20012825 A NO 20012825A NO 20012825 A NO20012825 A NO 20012825A NO 20012825 L NO20012825 L NO 20012825L
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- particles
- inhalation
- powders
- preparation
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 5
- 239000002245 particle Substances 0.000 title abstract 4
- 239000000843 powder Substances 0.000 title abstract 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 239000011149 active material Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Glanulating (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Carbon And Carbon Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9827145.5A GB9827145D0 (en) | 1998-12-09 | 1998-12-09 | Improvements in or relating to powders |
| PCT/GB1999/004156 WO2000033811A2 (fr) | 1998-12-09 | 1999-12-09 | Ameliorations apportees a des poudres |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012825D0 NO20012825D0 (no) | 2001-06-08 |
| NO20012825L true NO20012825L (no) | 2001-06-08 |
Family
ID=10843948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012825A NO20012825L (no) | 1998-12-09 | 2001-06-08 | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6989155B1 (fr) |
| EP (1) | EP1137399B1 (fr) |
| JP (1) | JP4410942B2 (fr) |
| KR (1) | KR20010101138A (fr) |
| CN (1) | CN1334723A (fr) |
| AT (1) | ATE240093T1 (fr) |
| AU (1) | AU770461B2 (fr) |
| BR (1) | BR9916102A (fr) |
| CA (1) | CA2353448C (fr) |
| CZ (1) | CZ20012043A3 (fr) |
| DE (1) | DE69907951T2 (fr) |
| DK (1) | DK1137399T3 (fr) |
| EA (1) | EA004045B1 (fr) |
| ES (1) | ES2198973T3 (fr) |
| GB (1) | GB9827145D0 (fr) |
| HU (1) | HUP0104513A3 (fr) |
| MX (1) | MXPA01005584A (fr) |
| NO (1) | NO20012825L (fr) |
| NZ (1) | NZ511965A (fr) |
| PL (1) | PL348831A1 (fr) |
| PT (1) | PT1137399E (fr) |
| SK (1) | SK284775B6 (fr) |
| TR (1) | TR200101591T2 (fr) |
| WO (1) | WO2000033811A2 (fr) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US9006175B2 (en) * | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| DK1808438T3 (da) | 1999-06-29 | 2014-10-27 | Mannkind Corp | Rensning og stabilisering af peptid og proteiner i lægemidler |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| JP2001151673A (ja) * | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | 吸入用粉末製剤の製造方法 |
| EP1296651B2 (fr) | 2000-06-27 | 2019-07-17 | Vectura Limited | Procede permettant de produire des particules destinees a etre utilisees dans une composition pharmaceutique |
| DK1296651T3 (da) * | 2000-06-27 | 2008-02-11 | Vectura Ltd | Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat |
| DK1337240T4 (en) | 2000-11-30 | 2015-01-05 | Vectura Ltd | A process for the preparation of particles for use in a pharmaceutical composition |
| DK2283818T3 (en) † | 2000-11-30 | 2017-10-16 | Vectura Ltd | Process for preparing particles for use in a pharmaceutical composition |
| EP1337239B2 (fr) | 2000-11-30 | 2015-11-25 | Vectura Limited | Particules servant dans une composition pharmaceutique |
| CA2465675C (fr) | 2001-11-20 | 2008-06-10 | Advanced Inhalation Research, Inc. | Compositions particulaires ameliorees destinees a etre administrees par voie pulmonaire |
| CA2478327A1 (fr) * | 2002-03-20 | 2003-10-02 | Advanced Inhalation Research, Inc. | Preparations d'hormone de croissance humaine (hch) destinees a etre administrees par voie pulmonaire |
| AU2003220125B2 (en) | 2002-03-20 | 2006-06-15 | Mannkind Corporation | Inhalation apparatus |
| US20110123574A1 (en) * | 2002-03-20 | 2011-05-26 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| EP1487411B1 (fr) * | 2002-03-20 | 2019-01-02 | Civitas Therapeutics, Inc. | Formulations therapeutiques soutenues respirables |
| US7754242B2 (en) | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| AU2004228757A1 (en) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| PL1786784T3 (pl) | 2004-08-20 | 2011-04-29 | Mannkind Corp | Kataliza syntezy diketopiperazyn |
| EP2314298B1 (fr) | 2004-08-23 | 2015-05-27 | MannKind Corporation | Microparticules comprenant des sels de diketopiperazine permettant l'administration de médicaments |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| NZ556709A (en) * | 2005-02-10 | 2009-09-25 | Glaxo Group Ltd | Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| CA2617909C (fr) * | 2005-08-05 | 2014-02-04 | 3M Innovative Properties Company | Compositions presentant une aptitude a l'ecoulement amelioree |
| AU2006290870B2 (en) | 2005-09-14 | 2013-02-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| DK1986679T3 (da) * | 2006-02-22 | 2017-11-20 | Mannkind Corp | Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof |
| DE102006030164A1 (de) * | 2006-06-29 | 2008-01-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Pulver |
| DE102006053375A1 (de) * | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
| US20090048155A1 (en) | 2007-08-15 | 2009-02-19 | Endacea, Inc. | Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| US9522916B2 (en) | 2007-12-21 | 2016-12-20 | Constance Neely Wilson | A1 adenosine receptor antagonists |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| CN103252007B (zh) | 2008-06-13 | 2016-06-22 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
| JP5479465B2 (ja) | 2008-06-20 | 2014-04-23 | マンカインド コーポレイション | 吸入努力をリアルタイムにプロファイルする対話式機器および方法 |
| TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| ES2739352T3 (es) | 2009-02-26 | 2020-01-30 | Glaxo Group Ltd | Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol |
| EP2676695A3 (fr) | 2009-03-11 | 2017-03-01 | MannKind Corporation | Appareil, système et procédé de mesure de résistance d'un inhalateur |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
| WO2011056889A1 (fr) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | Appareil et méthode de simulation d'efforts d'inhalation |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| WO2011094208A2 (fr) | 2010-01-26 | 2011-08-04 | Endacea, Inc. | Procédés et compositions pharmaceutiques pour la prévention et le traitement d'une insuffisance rénale |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| US20130164338A1 (en) * | 2010-08-30 | 2013-06-27 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| CA3086367A1 (fr) | 2010-09-29 | 2012-04-05 | Pulmatrix Operating Company, Inc. | Poudres seches a cations metalliques monovalents pour inhalation |
| AU2015249177B2 (en) * | 2010-11-09 | 2017-08-03 | Mannkind Corporation | Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
| ES2732818T3 (es) * | 2010-11-09 | 2019-11-26 | Mannkind Corp | Composición que comprende un agonista de receptores de serotonina y una dicetopiperazina para tratar migrañas |
| CN105667994B (zh) | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
| RU2448717C1 (ru) * | 2011-04-20 | 2012-04-27 | Закрытое акционерное общество Научно-производственное предприятие "Тринита" | Способ получения антикоагулянтно-фибринолитического средства на основе гепарина |
| WO2012174472A1 (fr) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | Microparticules de dicétopipérazine de capacité élevée |
| DK2739268T3 (en) | 2011-08-01 | 2019-02-25 | Univ Monash | PROCEDURE AND FORMULATION FOR INHALATION |
| WO2013063160A1 (fr) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Procédés et compositions pour traiter la douleur |
| SG11201500218VA (en) | 2012-07-12 | 2015-03-30 | Mannkind Corp | Dry powder drug delivery systems and methods |
| EP2911690A1 (fr) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Compositions et procédés de vaccin antigrippal inhalable |
| WO2014106727A1 (fr) | 2013-01-03 | 2014-07-10 | Vectura Limited | Inhalateur et formulation |
| EP2970149B1 (fr) | 2013-03-15 | 2019-08-21 | MannKind Corporation | Compositions de dicétopipérazine microcristallines et procédés |
| AU2014248455B2 (en) | 2013-04-01 | 2018-12-06 | Pulmatrix Operating Company, Inc. | Tiotropium dry powders |
| CN105451716A (zh) | 2013-07-18 | 2016-03-30 | 曼金德公司 | 热稳定性干粉药物组合物和方法 |
| WO2015021064A1 (fr) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Appareil d'insufflation et procédés |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| CA2965759C (fr) | 2014-10-31 | 2023-12-12 | Glaxosmithkline Intellectual Property Development Limited | Polypeptides en poudre presentant moins d'impuretes de disulfide comprenant des materiaux cationiques divalents |
| EP3340982B1 (fr) | 2015-08-26 | 2021-12-15 | Achillion Pharmaceuticals, Inc. | Composés pour le traitement de troubles immunitaires et inflammatoires |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| EP3455219A4 (fr) | 2016-05-10 | 2019-12-18 | C4 Therapeutics, Inc. | Dégronimères de c3-glutarimide liés à une amine pour la dégradation de protéines cibles |
| AU2017290593A1 (en) | 2016-06-27 | 2019-01-03 | Achillion Pharmaceuticals, Inc. | Quinazoline and indole compounds to treat medical disorders |
| CN110603252A (zh) | 2017-03-01 | 2019-12-20 | 艾其林医药公司 | 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物 |
| EP3592352A1 (fr) * | 2017-03-07 | 2020-01-15 | Philip Morris Products S.a.s. | Formulations de nicotine à inhaler et procédés de production et d'utilisation de celles-ci |
| CN118440096A (zh) | 2017-06-20 | 2024-08-06 | C4医药公司 | 用于蛋白降解的n/o-连接的降解决定子和降解决定子体 |
| US20190177588A1 (en) * | 2017-12-12 | 2019-06-13 | Xotramorphic LLC | Compositions, Methods, and Systems For Producing Flocculent Materials for Special Effects |
| KR20210018199A (ko) | 2018-03-26 | 2021-02-17 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스의 분해를 위한 세레블론 결합제 |
| CN110441198A (zh) * | 2018-05-03 | 2019-11-12 | 人福普克药业（武汉）有限公司 | 一种检测尼达尼布软胶囊中尼达尼布粒径的方法 |
| WO2020041301A1 (fr) | 2018-08-20 | 2020-02-27 | Achillion Pharmaceuticals, Inc. | Composés pharmaceutiques pour le traitement de troubles médicaux du facteur d du complément |
| WO2020081723A1 (fr) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Promédicaments de monoxyde de carbone pour le traitement de troubles médicaux |
| KR20210152515A (ko) | 2019-04-12 | 2021-12-15 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스 및 아이올로스의 트리시클릭 분해제 |
| WO2021127452A1 (fr) | 2019-12-19 | 2021-06-24 | Georgia State University Research Foundation, Inc. | Composés pour le traitement d'infections bactériennes et la potentialisation d'antibiotiques |
| US20250197403A1 (en) | 2020-02-20 | 2025-06-19 | Achillion Pharmaceuticals, Inc. | Heteroaryl compounds for treatment of complement factor d mediated disorders |
| AU2021231898A1 (en) | 2020-03-05 | 2022-10-27 | C4 Therapeutics, Inc. | Compounds for targeted degradation of BRD9 |
| CN116437913A (zh) | 2020-09-23 | 2023-07-14 | 艾其林医药公司 | 用于治疗补体介导的病症的药物化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| ES2237767T3 (es) | 1995-04-14 | 2005-08-01 | Nektar Therapeutics | Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada. |
| GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| CN1188111C (zh) * | 1999-10-29 | 2005-02-09 | 耐科塔医药公司 | 分散性得到改进的干粉组合物 |
-
1998
- 1998-12-09 GB GBGB9827145.5A patent/GB9827145D0/en not_active Ceased
-
1999
- 1999-12-09 PT PT99958404T patent/PT1137399E/pt unknown
- 1999-12-09 HU HU0104513A patent/HUP0104513A3/hu unknown
- 1999-12-09 TR TR2001/01591T patent/TR200101591T2/xx unknown
- 1999-12-09 DE DE69907951T patent/DE69907951T2/de not_active Expired - Lifetime
- 1999-12-09 US US09/857,392 patent/US6989155B1/en not_active Expired - Fee Related
- 1999-12-09 CZ CZ20012043A patent/CZ20012043A3/cs unknown
- 1999-12-09 EP EP99958404A patent/EP1137399B1/fr not_active Expired - Lifetime
- 1999-12-09 AT AT99958404T patent/ATE240093T1/de not_active IP Right Cessation
- 1999-12-09 DK DK99958404T patent/DK1137399T3/da active
- 1999-12-09 JP JP2000586305A patent/JP4410942B2/ja not_active Expired - Fee Related
- 1999-12-09 CN CN99816052A patent/CN1334723A/zh active Pending
- 1999-12-09 AU AU15777/00A patent/AU770461B2/en not_active Ceased
- 1999-12-09 KR KR1020017007067A patent/KR20010101138A/ko not_active Ceased
- 1999-12-09 SK SK777-2001A patent/SK284775B6/sk unknown
- 1999-12-09 WO PCT/GB1999/004156 patent/WO2000033811A2/fr not_active Ceased
- 1999-12-09 PL PL99348831A patent/PL348831A1/xx not_active IP Right Cessation
- 1999-12-09 EA EA200100636A patent/EA004045B1/ru not_active IP Right Cessation
- 1999-12-09 ES ES99958404T patent/ES2198973T3/es not_active Expired - Lifetime
- 1999-12-09 BR BR9916102-8A patent/BR9916102A/pt not_active Application Discontinuation
- 1999-12-09 CA CA2353448A patent/CA2353448C/fr not_active Expired - Fee Related
- 1999-12-09 MX MXPA01005584A patent/MXPA01005584A/es unknown
- 1999-12-09 NZ NZ511965A patent/NZ511965A/en not_active IP Right Cessation
-
2001
- 2001-06-08 NO NO20012825A patent/NO20012825L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002531487A (ja) | 2002-09-24 |
| EA200100636A1 (ru) | 2001-12-24 |
| DE69907951T2 (de) | 2004-03-11 |
| JP4410942B2 (ja) | 2010-02-10 |
| DE69907951D1 (de) | 2003-06-18 |
| EP1137399B1 (fr) | 2003-05-14 |
| CA2353448A1 (fr) | 2000-06-15 |
| MXPA01005584A (es) | 2003-07-14 |
| BR9916102A (pt) | 2001-09-04 |
| EA004045B1 (ru) | 2003-12-25 |
| AU1577700A (en) | 2000-06-26 |
| CA2353448C (fr) | 2010-02-23 |
| SK7772001A3 (en) | 2001-12-03 |
| WO2000033811A2 (fr) | 2000-06-15 |
| US6989155B1 (en) | 2006-01-24 |
| AU770461B2 (en) | 2004-02-19 |
| PL348831A1 (en) | 2002-06-17 |
| TR200101591T2 (tr) | 2001-11-21 |
| ES2198973T3 (es) | 2004-02-01 |
| SK284775B6 (sk) | 2005-11-03 |
| CN1334723A (zh) | 2002-02-06 |
| NZ511965A (en) | 2003-09-26 |
| HUP0104513A3 (en) | 2003-12-29 |
| HUP0104513A2 (hu) | 2002-03-28 |
| GB9827145D0 (en) | 1999-02-03 |
| DK1137399T3 (da) | 2003-08-18 |
| PT1137399E (pt) | 2003-09-30 |
| KR20010101138A (ko) | 2001-11-14 |
| NO20012825D0 (no) | 2001-06-08 |
| ATE240093T1 (de) | 2003-05-15 |
| WO2000033811A3 (fr) | 2000-10-12 |
| EP1137399A2 (fr) | 2001-10-04 |
| CZ20012043A3 (cs) | 2001-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012825D0 (no) | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering | |
| GB9807232D0 (en) | Aerosol composition | |
| AP1861A (en) | Dry powder inhalation system for transpulmonary administration | |
| WO2005079755A3 (fr) | Poudres antagonistes de l'interleukine-13, particules sechees par pulverisation, et procedes | |
| AU2003258706A1 (en) | Powder inhaler | |
| DK1131059T3 (da) | Tørpulver til inhalation | |
| MY132999A (en) | New formulation for inhalation | |
| CA2183577A1 (fr) | Methodes et compositions pour l'administration pulmonaire d'insuline | |
| CA2211874A1 (fr) | Particules porteuses a utiliser dans des inhalateurs a poudre seche | |
| WO2005025535A3 (fr) | Procedes de preparation de compositions pharmaceutiques | |
| CA2447099A1 (fr) | Administration par voie pulmonaire de composes destines au traitement de la migraine | |
| TR200101442T2 (tr) | HFA 227 ve HFA 137 ihtiva eden farmasötik aeorosol bileşimi | |
| EA199800983A1 (ru) | Диспергируемые композиции на основе макромолекулярных соединений | |
| WO2003087335A3 (fr) | Conservation de matieres bioactives par sechage par pulverisation | |
| CA2277914A1 (fr) | Nouvelle formulation pour inhalation ayant une densite en vrac coulee de 0,28 a 0,38 g/ml et contenant du budesonide | |
| MXPA03000321A (es) | Formulaciones de macrolido para inhalacion y metodos de tratamiento de infecciones endobronquiales. | |
| MXPA03003785A (es) | Suspension de una proteina epi-hne, proceso de preparacion de la misma, aerosol en polvo seco derivado de la misma, composiciones farmaceuticas conteniendo dicha suspension o aerosol y sus usos. | |
| CA2413692A1 (fr) | Procede permettant de produire des particules destinees a etre utilisees dans une composition pharmaceutique | |
| AR007807A1 (es) | Polvo de aspartame para la aplicacion en mezclas de polvos y procedimiento para su preparacion | |
| MX2022015578A (es) | Composiciones en polvo de anatabina. | |
| GB2528945A (en) | Adsorbent particle process management |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |